D. Felmingham, C. Feldman, W. Hryniewicz, K. Klugman, S. Kohno, D. E

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

R. Leclercq Clinical Microbiology and Infection

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

R. Dumke, H. von Baum, P.C. Lück, E. Jacobs

Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period J. Liñares, C. Ardanuy, R. Pallares, A.

Approach to diagnosis of infective endocarditis

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany.

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties J. Maugein, D. Guillemot, M.J. Dupont, T. Fosse,

Use of antimicrobials and resistance in bacteria isolated from blood cultures in a Danish county from 1992 to 1995 Thomas Lund S⊘rensen, Niels Frimodt-M⊘ller,

R. Cantón Clinical Microbiology and Infection

Didier Guillemot, Claude Carbon Clinical Microbiology and Infection

Current patterns and evolution of antibiotic resistance among bacterial pathogens involved in acute otitis media Fernando Baquero, Rafael Cantón, Fernando.

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

Carriage and antibiotic resistance of respiratory pathogens and molecular epidemiology of antibiotic-resistant Streptococcus pneumoniae colonizing children.

P. Davey, C. Pagliari, A. Hayes Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription B. Maraha, M. Bonten, H. Fiolet,

D.E. Low Clinical Microbiology and Infection

The role of fourth-generation cephalosporins in the treatment of infections caused by penicillin-resistant streptococci Keith Klugman, Fred Goldstein,

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

Prevalence of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae isolates reported by laboratories in the southern and eastern.

Training for the infectious diseases speciality in Norway

The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model Matthew O'Brien, Thuy Quach,

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A

Antibiotic usage and the incidence of resistance

Prevalence of Streptococcus pneumoniae isolates bearing macrolide resistance genes in association with integrase genes of conjugative transposons in Japan

Elements of design: the knowledge on which we build

Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan P.-R. Hsueh, J.-M. Shyr, J.-J. Wu Clinical.

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

Laboratory diagnosis of Clostridium difficile disease

T.M. File Clinical Microbiology and Infection

Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.

In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany.

Abstracts cont. Clinical Microbiology and Infection

C. Oprica, C.E. Nord Clinical Microbiology and Infection

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Clinical infection services—the Leiden experience

Ethan Rubinstein, Itzhak Levy Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Pharmacodynamic and pharmacokinetic considerations in antimicrobial selection: focus on telithromycin G. Drusano Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Overview of cefixime use in community-acquired infections

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

Clinical and molecular epidemiology of chromosome-mediated resistance to third- generation cephalosporins in Enterobacter isolates in eastern France D.

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

Moving from recommendation to implementation and audit: Part 1

Carratalà J. Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

N.C. Weightman, S. Mitra, P.T. Kipling

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Presentation transcript:

Surveillance of resistance in bacteria causing community‐acquired respiratory tract infections D. Felmingham, C. Feldman, W. Hryniewicz, K. Klugman, S. Kohno, D.E. Low, C. Mendes, A.C. Rodloff Clinical Microbiology and Infection Volume 8, Pages 12-42 (January 2002) DOI: 10.1046/j.1469-0691.8.s.2.5.x Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Prevalence of penicillin nonsusceptibility in Streptococcus pneumoniae across the world (various sources, data correct up to February 2001). Clinical Microbiology and Infection 2002 8, 12-42DOI: (10.1046/j.1469-0691.8.s.2.5.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Consumption of βlactam (A) and macrolide (B) antibiotics in Central and Eastern European countries (various sources). Abbreviations: AMP=ampicillin; AMX=amoxicillin; AMX/CLAV=amoxicillin–clavulanate; AZI=azithromycin; CLA=clarithromycin; CLIN=clindamycin; DDD=defined daily doses; ERY=erythromycin; LINC=lincomycin; PEN G=penicillin G (benzylpenicillin); PEN V=penicillin V (phenoxymethylpenicillin); SPIR=spiramycin. Clinical Microbiology and Infection 2002 8, 12-42DOI: (10.1046/j.1469-0691.8.s.2.5.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Prevalence of nonsusceptibility to penicillin (PEN), erythromycin (ERY) and tetracycline (TET) among Streptococcus pneumoniae isolates from Asian countries participating in PROTEKT [56]. Clinical Microbiology and Infection 2002 8, 12-42DOI: (10.1046/j.1469-0691.8.s.2.5.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 4 Changes in penicillin and macrolide‐resistance prevalence in respiratory Streptococcus pneumoniae isolates in South Africa [21,86]. Clinical Microbiology and Infection 2002 8, 12-42DOI: (10.1046/j.1469-0691.8.s.2.5.x) Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions